Victoria Niklas, MD
VP, Innovation and Medical Communication
Dr. Niklas, MD earned her Master’s Degree in Biochemistry and Molecular Biology from Harvard University and MD from Harvard Medical School. She went on to complete a residency in Pediatrics at the Children’s Hospital of Los Angeles and a fellowship in Perinatal and Neonatal Medicine at UCLA.
As VP of Innovation and Medical Communication, Victoria leads the Scientific Advisory Board in developing next-generation products from human milk. She also continues to serve as a Professor of Pediatrics at the UCLA David Geffen School of Medicine and in the practice of neonatology at the Olive View UCLA Medical Center.
Dr. Niklas is passionate about uncovering therapeutic potentials in human milk and transforming that knowledge into meaningful solutions in health care. Prior to joining Prolacta, she served as the Director of the Neonatal Intensive Care Unit and Newborn Services at Nemours Children’s Hospital and subsequently at the Olive View–UCLA Medical Center. Dr. Niklas’ research has focused on neonatal gastrointestinal immunology and the role of breast milk in reducing infections and necrotizing enterocolitis in premature newborns. She has also been responsible for groundbreaking research on lactoferrin, a protein found in high abundance in breast milk, in reducing hospital acquired infections in preterm newborns.
Dr. Niklas is an experienced neonatologist, educator, mentor and a leader of neonatal intensive care. She is a recognized expert in neonatal intestinal immunology, mouse models of intestinal immune T cell development and in the role of the gut microbiome in the pathogenesis of necrotizing enterocolitis and other diseases that occur throughout life.